Micro-Dosing GLP-1s for Menopause: Benefits, Risks, and What Women Need to Grasp

As many as 70% of women experience weight gain during the menopausal transition, often finding that previous weight management strategies develop into ineffective. Increasingly, women are turning to micro-dosing GLP-1 medications – drugs initially designed for type 2 diabetes – to manage symptoms and weight gain associated with perimenopause and menopause. But is this practice safe, and what are the potential risks and benefits?

What are GLP-1s?

GLP-1 medications like Wegovy, Ozempic, Zepbound, and Mounjaro are synthetic versions of the glucagon-like peptide-1 (GLP-1) hormone, which naturally regulates blood sugar, appetite, and feelings of fullness. Originally developed to treat type 2 diabetes, these drugs have gained popularity for weight loss due to their ability to promote satiety and reduce food intake. [Source: Essence]

Micro-Dosing for Menopause: A Growing Trend

Jana Stewart, a 54-year-old hormone and midlife health coach and bodybuilder, found that traditional diet and exercise methods stopped working during perimenopause, leading her to explore GLP-1 medications. After initial weight loss with a full dose of Wegovy, she now micro-doses (10 units weekly) to maintain her weight and manage cravings and inflammation. [Source: Essence] Micro-dosing involves using a lower-than-prescribed dose of the medication, often with the goal of minimizing side effects while still experiencing benefits.

Why are Women Turning to GLP-1s During Menopause?

Weight gain is a common symptom of menopause, with women potentially gaining 22 to 25 pounds from the start of perimenopause. [Source: Essence] For Black women, this can be particularly pronounced, with a tendency to gain weight in the abdominal area. [Source: Essence] GLP-1s can facilitate manage weight by increasing feelings of fullness and regulating blood sugar, alongside a healthy diet and exercise. [Source: Essence] Beyond weight management, some women report benefits like decreased inflammation, improved mental clarity, and reduced cravings.

Potential Risks and Side Effects

While GLP-1s can be effective, they are not without potential side effects. Common side effects include gastrointestinal issues like diarrhea, constipation, and stomach pain. More serious side effects, such as gastroparesis (stomach paralysis), have led to numerous class action lawsuits against manufacturers like Novo Nordisk and Eli Lilly since 2023. [Source: Essence] Some users have also reported hair loss, loose skin, and a gaunt facial appearance. The long-term risks of GLP-1 use are still being studied, as the drugs have only been widely used for weight loss since 2017.

Micro-dosing may reduce the severity of side effects, but hormonal shifts during menopause can compound potential issues like muscle loss and hair thinning. Maintaining adequate protein intake, a nutrient-rich diet, and regular weight training are crucial for mitigating these risks. [Source: Essence]

The Importance of Informed Decision-Making

Experts emphasize the importance of open communication with healthcare providers and a comprehensive approach to managing menopausal symptoms. While GLP-1s can be a valuable tool for some women, they are not a magic bullet. Lifestyle factors like sleep, strength training, and a healthy diet remain essential. [Source: LinkedIn] Women should be aware of the potential risks and benefits and make informed decisions based on their individual needs and health status.

Jana Stewart emphasizes that women shouldn’t suffer in silence and that resources are available to support them through this transition. [Source: Essence]